title: Pulmonary hemorrhage during GP IIb/IIIa inhibitor therapy: an uncommon but life-threatening (and under-recognized) complication.
authors.affiliation: Lenox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA. gdangas@crf.org
authors.forename: George
authors.initials: G
authors.lastname: Dangas
authors.forename: Ioannis
authors.initials: I
authors.lastname: Iakovou
mesh_terms: D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D017211:Treatment Failure
chemical_list: D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex